The predictive factors for refractory ascites in cirrhotic patients

被引：0
|
作者：
Fierbinteanu-Braticevici, C [1 ]
Tribus, L [1 ]
Andronescu, D [1 ]
机构：
[1] Univ Hosp, Bucharest, Romania
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
671
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [41] Development of refractory cirrhotic ascites: What are the critical determinants?
    Kamean, J
    Gitlin, N
    Martin, L
    Boyer, T
    HEPATOLOGY, 1996, 24 (04) : 1295 - 1295
  • [42] Predictive factors in cirrhotic patients with upper gastrointestinal bleeding
    Goldis, A.
    Ratiu, I.
    Diaconescu, R.
    Lazar, D.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 : 40 - 41
  • [43] Predictive factors for failure to control bleeding in cirrhotic patients
    Vivas, S
    Rodriguez, M
    Rodrigo, L
    JOURNAL OF HEPATOLOGY, 2000, 33 (01) : 168 - 168
  • [44] Microbial epidemiology, risk factors and outcome of SBP in cirrhotic patients with ascites
    Schwabl, P.
    Reiberger, T.
    Bucsics, T.
    Soucek, K.
    Payer, B. A.
    Blacky, A.
    Hirschl, A. M.
    Ferlitsch, A.
    Trauner, M.
    Peck-Radosavljevic, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (15-16) : 572 - 572
  • [45] Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
    Lv, Xin-Yue
    Ding, Hui-Guo
    Zheng, Jun-Fu
    Fan, Chun-Lei
    Li, Lei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (02) : 199 - 218
  • [46] MICROBIAL EPIDEMIOLOGY, RISK FACTORS AND OUTCOME OF SBP IN CIRRHOTIC PATIENTS WITH ASCITES
    Reiberger, T.
    Schwabl, P.
    Bucsics, T.
    Soucek, K.
    Payer, B. A.
    Blacky, A.
    Hirschl, A.
    Ferlitsch, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S53 - S53
  • [47] THE PHARMACOKINETICS OF TERLIPRESSIN ADMINISTERED AS A CONTINUOUS INFUSION IN SIX CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES.
    Fischer, James
    Markham, Penelope
    Bajaj, Jasmohan S.
    Gavis, Edith A.
    Smith, Denise
    Yeramian, Patrick
    HEPATOLOGY, 2019, 70 : 190A - 191A
  • [48] Transjugular intrahepatic portosystemic shunt in cirrhotic elderly patients with refractory ascites - to do or not to do?
    Thoele, Lena
    Schultalbers, Marie
    Tergast, Tammo Lambert
    Gerbel, Svetlana
    Hinrichs, Jan
    Simon, Nicolas
    Cornberg, Markus
    Manns, Michael P.
    Meyer, Bernhard
    Maasoumy, Benjamin
    JOURNAL OF HEPATOLOGY, 2020, 73 : S766 - S766
  • [49] Survival predictors in cirrhotic patients with refractory ascites treated with transjugular intrahepatic portosystemic shunt
    Aicart-Ramos, M.
    Ibanez-Samaniego, L.
    Martinez-Lozano, H.
    Catalina, M. -V.
    Rodriguez-de Santiago, E.
    Banares, R.
    Albillos, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S390 - S391
  • [50] Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
    Xin-Yue Lv
    Hui-Guo Ding
    Jun-Fu Zheng
    Chun-Lei Fan
    Lei Li
    World Journal of Gastroenterology, 2020, (02) : 199 - 218
12345